Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-05

Clinical Trial Update: The Use of Liraglutide in Brain Death [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating liraglutide for brain death has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Brain Death | Phase 3 | Status: COMPLETED